LivaNova (LIVN) Competitors $48.52 +1.16 (+2.45%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$48.54 +0.01 (+0.03%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. STVN, IRTC, GKOS, BLCO, SLNO, TMDX, INSP, NVST, PRCT, and WRBYShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. LivaNova vs. Its Competitors Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics Warby Parker LivaNova (NASDAQ:LIVN) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, earnings and dividends. Do analysts recommend LIVN or STVN? LivaNova presently has a consensus target price of $59.29, suggesting a potential upside of 22.19%. Given LivaNova's stronger consensus rating and higher probable upside, equities research analysts plainly believe LivaNova is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 Which has more volatility & risk, LIVN or STVN? LivaNova has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Is LIVN or STVN more profitable? Stevanato Group has a net margin of 11.73% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova-16.13% 14.57% 6.91% Stevanato Group 11.73%10.34%6.21% Do insiders and institutionals have more ownership in LIVN or STVN? 97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by company insiders. Comparatively, 0.7% of Stevanato Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher earnings & valuation, LIVN or STVN? Stevanato Group has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B2.11$63.23M-$4.09-11.86Stevanato Group€1.15B6.40€127.45M€0.5444.81 Does the media favor LIVN or STVN? In the previous week, LivaNova had 3 more articles in the media than Stevanato Group. MarketBeat recorded 15 mentions for LivaNova and 12 mentions for Stevanato Group. LivaNova's average media sentiment score of 1.05 beat Stevanato Group's score of 0.96 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stevanato Group 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLivaNova beats Stevanato Group on 10 of the 16 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.58B$6.80B$5.48B$9.57BDividend YieldN/A1.35%3.99%4.17%P/E Ratio-12.4724.4429.9425.14Price / Sales2.1154.22398.9486.71Price / Cash11.1720.5535.9458.58Price / Book2.365.528.105.59Net Income$63.23M$178.18M$3.26B$265.48M7 Day Performance17.97%-0.57%0.68%1.22%1 Month Performance3.99%-5.36%2.46%0.39%1 Year Performance7.82%6.18%27.69%23.47% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova2.289 of 5 stars$48.52+2.4%$59.29+22.2%+8.5%$2.58B$1.25B-12.472,900News CoverageEarnings ReportSTVNStevanato Group2.1493 of 5 stars€25.58+1.8%N/A+23.3%€7.75B€1.19B50.165,521News CoverageAnalyst RevisionIRTCiRhythm Technologies1.8142 of 5 stars$164.98+0.0%$157.30-4.7%+135.0%$5.30B$591.84M-56.312,000Insider TradeGKOSGlaukos4.0015 of 5 stars$87.52+1.6%$127.42+45.6%-24.1%$4.92B$383.48M-53.04780BLCOBausch + Lomb3.1004 of 5 stars$13.76+1.9%$15.56+13.0%-10.0%$4.78B$4.79B-17.6413,500SLNOSoleno Therapeutics4.5817 of 5 stars$84.12-2.2%$108.70+29.2%+79.0%$4.33BN/A-18.2130News CoveragePositive NewsEarnings ReportAnalyst ForecastTMDXTransMedics Group2.6411 of 5 stars$128.50+6.6%$123.00-4.3%-20.4%$4.11B$441.54M66.58210INSPInspire Medical Systems4.64 of 5 stars$130.79+3.7%$208.55+59.5%-59.1%$3.72B$802.80M60.271,246Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeNVSTEnvista3.4903 of 5 stars$20.48-1.7%$20.92+2.2%+31.2%$3.46B$2.51B63.9912,300PRCTPROCEPT BioRobotics3.292 of 5 stars$49.60-0.7%$84.13+69.6%-34.1%$2.76B$224.50M-29.18430Trending NewsEarnings ReportAnalyst ForecastGap DownWRBYWarby Parker2.0271 of 5 stars$24.47+3.7%$23.13-5.5%+67.2%$2.47B$771.32M-203.883,780Trending NewsAnalyst ForecastAnalyst RevisionGap Up Related Companies and Tools Related Companies STVN Alternatives IRTC Alternatives GKOS Alternatives BLCO Alternatives SLNO Alternatives TMDX Alternatives INSP Alternatives NVST Alternatives PRCT Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
